Exact Sciences
EXAS
#1543
Rank
โ‚ฌ10.60 B
Marketcap
57,31ย โ‚ฌ
Share price
5.86%
Change (1 day)
-11.70%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Net assets

Net assets on the balance sheet as of September 2024 : โ‚ฌ3.09 Billion

According to Exact Sciences's latest financial reports the company has โ‚ฌ3.09 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exact Sciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚ฌ2.84 B0.29%
2022-12-31$โ‚ฌ2.83 B-5.16%
2021-12-31$โ‚ฌ2.99 B64.58%
2020-12-31$โ‚ฌ1.81 B-11.01%
2019-12-31$โ‚ฌ2.04 B243.14%
2018-12-31$โ‚ฌ0.59 B37.23%
2017-12-31$โ‚ฌ0.43 B36.07%
2016-12-31$โ‚ฌ0.31 B6.63%
2015-12-31$โ‚ฌ0.29 B25.81%
2014-12-31$โ‚ฌ0.23 B142.5%
2013-12-31$โ‚ฌ97.98 M31.46%
2012-12-31$โ‚ฌ74.53 M15.93%
2011-12-31$โ‚ฌ64.29 M7.23%
2010-12-31$โ‚ฌ59.95 M1309.66%
2009-12-31$โ‚ฌ4.25 M-344.4%
2008-12-31$-โ‚ฌ1.75 Million-140.41%
2007-12-31$โ‚ฌ4.3 M-62.01%
2006-12-31$โ‚ฌ11.33 M-45.46%
2005-12-31$โ‚ฌ20.78 M-25.77%
2004-12-31$โ‚ฌ28 M188.3%
2003-12-31$โ‚ฌ9.71 M-73.52%
2002-12-31$โ‚ฌ36.68 M-45.06%
2001-12-31$โ‚ฌ66.76 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚ฌ0.70 B-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.13 B-63.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.27 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ75.49 B 2,337.36%๐Ÿ‡ซ๐Ÿ‡ท France